Page
%P
-
Article
Open AccessPembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
Pembrolizumab (PEM), an immune checkpoint inhibitor (ICI), is often used for triple-negative breast cancer, but can also be used to treat solid tumors that exhibit high microsatellite instability (MSI-High). H...